Skip to main content
SpringerLink
Log in

Stent Thrombosis: Historical Perspectives and Current Trends

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Coronary stents are now implanted in more than 70% of percutaneous coronary revascularization procedures. Early enthusiasm for improved acute angiographic results and limited restenosis was dampened initially by a high rate of stent thrombosis and later by the increased bleeding complications of aggressive and complex anticoagulation protocols designed to lower the stent thrombosis risk. More recently, routine high-pressure deployment strategies and anti-platelet drug regimens have lowered the incidence of stent thrombosis to approximately 1% without an increased bleeding risk. The timing of stent thrombosis has also changed from a median of 4–5 days to a median of 1 day after the stent procedure. Risk factors in earlier studies included stenting for threatened or abrupt closure, smaller vessels, longer lesions, and possibly left anterior descending artery lesion location. Modern studies have shown a slightly increased risk for multiple stent use, residual dissection, and smaller final lumen. Optimal therapy for stent thrombosis includes emergent revascularization and anti-thrombotic treatment, although the clinical consequences remain dire despite successful reperfusion. The use of platelet glycoprotein IIb/IIIa inhibitors, especially in high-risk situations may further reduce the incidence of stent thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.

    Google Scholar 

  2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.

    Google Scholar 

  3. Savage MP, Douglas JSJ, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. New Engl J Med 1997; 337:740-747.

    Google Scholar 

  4. Simes P, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): A randomized trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-1451.

    Google Scholar 

  5. Baim DS, Cutlip DE, Midei M, et al. Acute 30 day and late clinical events in the randomized parallel-group comparison of the ACS Multi-Link coronary stent system and the Palmaz-Schatz stent. Circulation 1997;96(suppl I):I-593.

    Google Scholar 

  6. Baim DS, Cutlip DE, Lansky AJ, Ricci GB, Fitzpatrick M. Results of the NIRVANA equivalency trial comparing the NIR Primo stent to the Palmz-Schatz stent. Circulation 1998;98(suppl I):I-661.

    Google Scholar 

  7. Heuser R, Kuntz R, Lansky A, et al. Six-month clinical and angiographic results of the SMART trial. J Am Coll Cardiol 1998;31(suppl A):64A.

    Google Scholar 

  8. Carrozza JP, Kereiakes D, Caputo RP, et al. Final acute 30-day and 6-month clinical and angiographic outcome from the multicenter randomized EXTRA trial comparing the operator mounted XT and Palmaz-Schatz coronary stent. Circulation 1998;98(suppl I):I-661.

    Google Scholar 

  9. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324: 13-17.

    Google Scholar 

  10. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706.

    Google Scholar 

  11. de Feyter PJ, De Scheerder I, van den Brand M, Laarman G, Suryapranata H, Serruys PW. Emergency stenting for refractory acute coronary artery occlusion during coronary angioplasty. Am J Cardiol 1990;66: 1147-1150.

    Google Scholar 

  12. Serruys PW, Di Mario C. Who was thrombogenic: The stent or the doctor? Circulation 1995;91:1891-1893. Editorial comment.

    Google Scholar 

  13. Schatz R. A view of vascular stents. Circulation 1989; 79:445-457.

    Google Scholar 

  14. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83: 148-161.

    Google Scholar 

  15. Carrozza JP Jr, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20: 328-337.

    Google Scholar 

  16. Herrmann HC, Buchbinder M, Clemen MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-819.

    Google Scholar 

  17. Roubin G, Cannon A, Agrawal S, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-927.

    Google Scholar 

  18. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.

    Google Scholar 

  19. Hearn JA, King SBd, Douglas JS Jr, Carlin SF, Lembo NJ, Ghazzal ZM. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation 1993;88:2086-2096.

    Google Scholar 

  20. Nath FC, Muller DW, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-627.

    Google Scholar 

  21. George BS, Voorhees WDd, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes. J Am Coll Cardiol 1993;22:135-143.

    Google Scholar 

  22. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993;21:1557-1563.

    Google Scholar 

  23. Foley JB, Brown RI, Penn IM. Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting. Am Heart J 1994;128:12-20.

    Google Scholar 

  24. Sutton JM, Ellis SG, Roubin GS, et al. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation 1994;89:1126-1137.

    Google Scholar 

  25. Savage MP, Fischman DL, Schatz RA, et al. Longterm angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1994;24:1207-1212.

    Google Scholar 

  26. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation 1995;92:2480-2487.

    Google Scholar 

  27. Goldberg S, Colombo A, Nakamura S, Almagor M, Maiello L, Tobis J. The benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 1994;24:996-1003.

    Google Scholar 

  28. Nakamura S, Colombo A, Gaglione S, et al. Intracoronary ultrasound observations during stent implantation. Circulation 1994;89:2026-2034.

    Google Scholar 

  29. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91:1676-1688.

    Google Scholar 

  30. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-222.

    Google Scholar 

  31. Albiero R, Hall P, Itoh A, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Circulation 1997; 95:1145-1156.

    Google Scholar 

  32. de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results form the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J 1998; 19:1214-1223.

    Google Scholar 

  33. Morice M, Zemour G, Benveniste E, et al. Intracoronary stenting without coumadin: 1 month results of a French multicenter study. Cathet Cardiovasc Diagn 1995;35:1-7.

    Google Scholar 

  34. Caputo R, Lopez J, Ho K, et al. Intravascular ultrasound analysis of routine high pressure post-dilation after Palmaz-Schatz stent deployment. J Am Coll Cardiol 1995;25:49A.

    Google Scholar 

  35. Mak K, Belli G, Ellis S, Moliterno D. Subacute stent thrombosis: Evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503.

    Google Scholar 

  36. Nakamura S, Hall P, Gaglione A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 1997;29: 1-7.

    Google Scholar 

  37. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.

    Google Scholar 

  38. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three anti-thrombotic drug regimens after coronary artery stenting. New Engl J Med 1998;338: 1665-1671.

    Google Scholar 

  39. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting-the full antocoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 1998;98:1507-1603.

    Google Scholar 

  40. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study. Circulation 1996;93:412-422.

    Google Scholar 

  41. Serruys PW, van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673-681.

    Google Scholar 

  42. Urban P, Macaya C, Rupprecht H, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multi-center aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126-2132.

    Google Scholar 

  43. Pepine C, Holmes D, Block P, et al. American College of Cardiology experts consensus document: Coronary artery stents. J Am Coll Cardiol 1996; 28: 782-794.

    Google Scholar 

  44. Gershlick A, Aggarwal R. Stent thrombosis revisited. Eur Heart J 1996;17:1623-1628.

    Google Scholar 

  45. Schuhlen H, Hadamitzky M, Walter H, Ulm K, Schomig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) trial. Circulation 1997;95:2015-2021.

    Google Scholar 

  46. Cutlip DE, Leon MB, Ho KKL, et al. Acute and 9-month clinical outcomes after "sub-optimal'' coronary stenting: Results from the stent anti-thrombotic regimen study (STARS) registry. J Am Coll Cardiol 1999; 34:698-706.

    Google Scholar 

  47. Sharis S, Cannon C, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998;129:394-405.

    Google Scholar 

  48. McTavish D, Faulds D, Goa K. Ticlopidine: An updated review of its pharmacology and therapeutic use in platelet dependent disorders. Drugs 1990;40: 238-259.

    Google Scholar 

  49. Gregorini L, Marco J, Fajadet J, et al. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol 1997;29:13-20.

    Google Scholar 

  50. Steinhubl S, Lauer M, Mukherjee D, et al. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q wave myocardial infarctions. J Am Coll Cardiol 1998; 32:1366-1370.

    Google Scholar 

  51. Steinhubl S, Balog C, Topol E. Ticlopidine pretreatment prior to stenting is associated with a sustained reduction in cardiac events out to 1 y: Results from the EPISTENT trial. Circulation (suppl) 1999;100:I-380.

    Google Scholar 

  52. Moussa I, Oetgenn M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-2366.

    Google Scholar 

  53. Mishkel G, Aguirre F, Ligon R, Rocha-Singh K, Lucore C. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 1999; 34:1884-1890.

    Google Scholar 

  54. Berger P, Bell M, Rihal C, et al. Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol 1999;34:1891-1894.

    Google Scholar 

  55. Linnemeier T. The Rx multi-link stent parallel registries to the ASCENT trial. J Inv Cardiol 1998;10(suppl B):55B-56B.

    Google Scholar 

  56. Cutlip D, Ho K, Baim D, et al. Predictors and clinical outcomes of stent thrombosis – a pooled analysis of 5000 patients from multicenter randomized trials. Circulation 1998;98(suppl I):I-498.

    Google Scholar 

  57. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988;78:1121-1127.

    Google Scholar 

  58. Moussa I, Mario CD, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors, and clinical outcome. J Am Coll Cardiol 1997;29:6-12.

    Google Scholar 

  59. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30 day clinical outcome of the French multicenter registry. Circulation 1996;94:1519-1527.

    Google Scholar 

  60. De Servi S, Repetto S, Klugmann S, et al. Stent thrombosis: Incidence and related factors in the R.I.S.E. registry (Registro Impianto Stent Endocoronarico). Catheter Cardiovasc Interv 1999;46:13-18.

    Google Scholar 

  61. Neumann FJ, Walter H, Richardt G, Schmitt C, Schomig A. Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart 1996;75:121-126.

    Google Scholar 

  62. Schomig A, Neumann FJ, Walter H, et al. Coronary stent placement in patients with acute myocardial infarction: Comparison of clinical and angiographic outcomes after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997;29:28-34.

    Google Scholar 

  63. Benzuly K, O'Neill W, Gangadharan V, et al. Stenting in acute myocardial infarction (STAMI): Bailout, conditional, and planned stents. J Am Coll Cardiol 1997;29(suppl A):456A.

    Google Scholar 

  64. Monassier J, Hamon M, Elias J, et al. Early versus late coronary stenting following acute myocardial infarction: Results of the STENTIM I Study (French registry of stenting in acute myocardial infarction). Cathet Cardiovasc Diagn 1997;42:243-248.

    Google Scholar 

  65. Stone G, Brodie B, Griffin J, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998;31:23-30.

    Google Scholar 

  66. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence randomized elective stenting in acute coronary occlusions (FRESCO) trial. J Am Coll Cardiol 1998;31:1234-1239.

    Google Scholar 

  67. Antoniucci D, Valenti R, Santoro G, et al. Primary coronary infarct artery stenting in acute myocardial infarction. Am J Cardiol 1999;84:505-510.

    Google Scholar 

  68. Grines C, Cox D, Stone G, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. New Engl J Med 1999;341: 1949-1956.

    Google Scholar 

  69. Liu MW, Voorhees WD, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary coronary balloon angioplasty: A Cook registry study. Am Heart J 1995;130:8-13.

    Google Scholar 

  70. Savage M, Fischman D, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study Investigators. J Am Coll Cardiol 1998;31:307-311.

    Google Scholar 

  71. Chan C, Tan A, Koh T, et al. Intracoronary stenting in the treatment of acute or threatened closure in angiographically small coronary arteries (<3.0mm) complicating percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;75:23-25.

    Google Scholar 

  72. Kerr A, Stewart R, Low C, Restieaux N, Wilkins G. Long stenting in native coronary arteries: Relation between vessel size and outcome. Cathet Cardiovasc Diagn 1998;44:170-174.

    Google Scholar 

  73. Greenbaum A, Popma J, O'Shaugnessy C, et al. Bailout stenting in small vessels: Preliminary in-hospital results of the ULTRA acute or threatened closure registry. J Am Coll Cardiol 1999;33(suppl A):68A.

    Google Scholar 

  74. Savage M, Fischman D, Kada F, Fry E, Kiernan F, Goldberg S. A randomized comparison of elective stenting and balloon angioplasty in the treatment of small coronary arteries. Circulation 1999;100(suppl I): I-503.

    Google Scholar 

  75. Muller D, Lansky A, Kaul U, et al. Small native coronary vessel stenting: Results from the the Asia-Pacific Mini-Crown registry. Circulation 1999; 100(suppl I):I-503.

    Google Scholar 

  76. Schomig A, Kastrati A, Mudra H, et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-2724.

    Google Scholar 

  77. Werner G, Gastmann O, Ferrari M, et al. Risk factors for acute and subacute stent thrombosis after highpressure stent implantation; a study by intravascular ultrasound. Am Heart J 1998;135:300-309.

    Google Scholar 

  78. Kobayashi Y, De Gregoriio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:660-662.

    Google Scholar 

  79. Ponde C, Watson P, Aroney C, et al. Multiple stent implantation in single coronary arteries: Acute results and six-month angiographic follow-up. Cathet Cardiovasc Diagn 1997;42:158-165.

    Google Scholar 

  80. Dirschinger J, Kastrati A, Neumann F, et al. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of highpressure inflation. Circulation 1999;100:918-923.

    Google Scholar 

  81. Mitchel JF, McKay RG. Treatment of acute stent thrombosis with local urokinase therapy using catheter-based, drug delivery systems: A case report. Cathet Cardiovasc Diagn 1995;34:149-154.

    Google Scholar 

  82. Hasdai D, Garratt KN, Holmes DR Jr., Berger PB, Schwartz RS, Bell MR. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 1996;28:361-367.

    Google Scholar 

  83. Jeong M, Owen W, Staab M, et al. Porcine model of stent thrombosis: Platelets are the primary component of acute stent closure. Cathet Cardiovasc Diagn 1996;38:38-43.

    Google Scholar 

  84. Berger P, Bell M, Hasdai D, Grill D, Melby S, Holmes DJ. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation 1999;99:248-253.

    Google Scholar 

  85. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med 1998;128:541-544.

    Google Scholar 

  86. Steinhubl SR, Tan WA, Foody JM, Topol EJ. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 1999;281:806-810.

    Google Scholar 

  87. Bachman F, Savcic M, Hauert J, Geudelin B, Kieffer G, Cariou R. Rapid onset of inhibition of ADP-induced platelet aggregation by a loading dose of clopidogrel. Eur Heart J 1996;17:263.

    Google Scholar 

  88. Caprie Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE). Lancet 1996;348:1329-1339.

    Google Scholar 

  89. Jauhar R, Savino S, Deutsch E, et al. Aspirin and clopidogrel combination therapy in coronary stenting: A prospective registry. Am J Cardiol 1998;82(suppl 7A):TCT-262: 96S.

    Google Scholar 

  90. The Epistent Investigators. Randomized placebocontrolled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.

    Google Scholar 

  91. Montalescot G, Barragan P, Wittenberg O, et al. Abciixmab associated with primary angioplasty and stenting in acute myocardial infarction: The ADMIRAL Study, 30-day final results. Circulation 1999;100(suppl I):I-87.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Rochester Medical Center, Rochester, NewYork, USA

    Donald E. Cutlip

Authors
  1. Donald E. Cutlip
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cutlip, D.E. Stent Thrombosis: Historical Perspectives and Current Trends. J Thromb Thrombolysis 10, 89–101 (2000). https://doi.org/10.1023/A:1018763108106

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018763108106

Search

Navigation